| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 4,600 |
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 4,600 |
-
|
-
| | | Operating Expenses | | Research Development | 26,566 | 26,200 | 23,716 | | Selling General and Administrative | 16,428 | 13,747 | 18,386 | | Non Recurring |
-
|
-
| 4,805 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (38,394) | (39,947) | (46,907) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 902 | 2,029 | 2,072 | | Earnings Before Interest And Taxes | (37,492) | (37,918) | (44,835) | | Interest Expense | 1,614 | 2,087 | 1,498 | | Income Before Tax | (39,106) | (40,005) | (46,333) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (39,106) | (40,005) | (46,333) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (39,106) | (40,005) | (46,333) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($39,106) | ($40,005) | ($46,333) |
|
0.29% Nasdaq 
0.00 (0.54%) 
Income Statement
